BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines cash Flow Statement — Operating cash flow ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Cash Flows (DB)
Latest, Q2 2026
463
Period ended Jun 30, 2026
Change on a year earlier
+75.6%
264 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
42
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash Flow Statement — Operating cash flow ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 463 | +75.6% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 201 | +356.5% | Form 10-Q (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 417 | +454.9% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 403 | +113.7% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 264 | -375.7% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 44.1 | -114.3% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 75.2 | -133.9% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 30, 2024 | 188 | -341.2% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | -95.6 | -67.5% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | -309 | -45.3% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | -222 | -30.4% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | -78.1 | -86.1% | Form 10-Q (filed 2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | -294 | -22.7% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | -564 | +138.3% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | -318 | -37.3% | Form 10-K (filed 2023-02-27) ↗ |
| Q3 2022 | Sep 30, 2022 | -562 | +13.4% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | -380 | -9.6% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | -237 | -289.1% | Form 10-Q (filed 2022-05-09) ↗ |
| Q4 2021 | Dec 31, 2021 | -508 | +52.8% | Form 10-K (filed 2022-02-28) ↗ |
| Q3 2021 | Sep 30, 2021 | -496 | +43.2% | Form 10-Q (filed 2021-11-04) ↗ |
| Q2 2021 | Jun 30, 2021 | -420 | +59.9% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 125 | -136.6% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | -332 | +24.4% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | -346 | +30.6% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | -263 | +470.3% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | -342 | +98.8% | Form 10-Q (filed 2020-05-11) ↗ |
| Q4 2019 | Dec 31, 2019 | -267 | +37.8% | Form 10-K (filed 2020-03-02) ↗ |
| Q3 2019 | Sep 30, 2019 | -265 | +100.5% | Form 10-Q (filed 2019-11-12) ↗ |
| Q2 2019 | Jun 30, 2019 | -46.1 | -60.6% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | -172 | +64.6% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | -194 | -306.9% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2018 | Sep 30, 2018 | -132 | -2,103.0% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jun 30, 2018 | -117 | +125.6% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | -105 | +192.7% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 93.7 | -459.0% | Form 10-K (filed 2018-02-28) ↗ |
| Q3 2017 | Sep 30, 2017 | 6.60 | -127.2% | Form 10-Q (filed 2017-11-13) ↗ |
| Q2 2017 | Jun 30, 2017 | -51.9 | +168.9% | Form 10-Q (filed 2017-08-09) ↗ |
| Q1 2017 | Mar 31, 2017 | -35.7 | +80.3% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | -26.1 | +55.4% | Form 10-K (filed 2017-03-22) ↗ |
| Q3 2016 | Sep 30, 2016 | -24.3 | +145.5% | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2016 | Jun 30, 2016 | -19.3 | +103.2% | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2016 | Mar 31, 2016 | -19.8 | +435.1% | Form 10-Q (filed 2016-05-12) ↗ |
| Q4 2015 | Dec 31, 2015 | -16.8 | – | Form 10-K (filed 2017-03-22) ↗ |
| Q3 2015 | Sep 30, 2015 | -9.90 | – | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2015 | Jun 30, 2015 | -9.50 | – | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2015 | Mar 31, 2015 | -3.70 | – | Form 10-Q (filed 2016-05-12) ↗ |
Breakdown
What makes up cash flow statement — operating cash flow ($m)
Cite this data
StockData. (2026). BeOne Medicines Cash Flow Statement — Operating cash flow ($M) ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_cash_flow
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.